Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4787432
Max Phase: Preclinical
Molecular Formula: C16H10F2N2O4S
Molecular Weight: 364.33
Molecule Type: Unknown
Associated Items:
ID: ALA4787432
Max Phase: Preclinical
Molecular Formula: C16H10F2N2O4S
Molecular Weight: 364.33
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(CN1C(=O)S/C(=C/c2ccco2)C1=O)Nc1ccc(F)cc1F
Standard InChI: InChI=1S/C16H10F2N2O4S/c17-9-3-4-12(11(18)6-9)19-14(21)8-20-15(22)13(25-16(20)23)7-10-2-1-5-24-10/h1-7H,8H2,(H,19,21)/b13-7+
Standard InChI Key: OOMXJEFRJHYTSG-NTUHNPAUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 364.33 | Molecular Weight (Monoisotopic): 364.0329 | AlogP: 3.23 | #Rotatable Bonds: 4 |
Polar Surface Area: 79.62 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.99 | CX Basic pKa: | CX LogP: 2.33 | CX LogD: 2.33 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.84 | Np Likeness Score: -2.66 |
1. Tilekar K,Upadhyay N,Hess JD,Macias LH,Mrowka P,Aguilera RJ,Meyer-Almes FJ,Iancu CV,Choe JY,Ramaa CS. (2020) Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potential., 202 [PMID:32634629] [10.1016/j.ejmech.2020.112603] |
Source(1):